Investigational Drug Details
| Drug ID: | D505 |
| Drug Name: | Equol |
| Synonyms: | |
| Type: | small molecule |
| DrugBank ID: | DB11674 |
| DrugBank Description: | Equol has been used in trials studying the treatment of Breast Cancer. |
| PubChem ID: | 91469 |
| CasNo: | 531-95-3 |
| Repositioning for NAFLD: | Yes |
| SMILES: | OC1=CC=C(C=C1)[C@H]1COC2=C(C1)C=CC(O)=C2 |
| Structure: |
|
| InChiKey: | ADFCQWZHKCXPAJ-GFCCVEGCSA-N |
| Molecular Weight: | 242.2699 |
| DrugBank Targets: | Estrogen receptor beta; Sex hormone-binding globulin |
| DrugBank MoA: | |
| DrugBank Pharmacology: | |
| DrugBank Indication: | |
| Targets: | |
| Therapeutic Category: | |
| Clinical Trial Progress: | |
| Latest Progress: |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0256 | NCT06039254 | PHASE1 | NOT_YET_RECRUITING | NO | 2023-09 | 2023-09-15 | Details |
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|